COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action?
| dc.contributor.author | Waddell, K | |
| dc.contributor.author | Wilson, MG | |
| dc.contributor.author | Gauvin, François-Pierre | |
| dc.contributor.author | Mansilla, C | |
| dc.contributor.author | Moat, KA | |
| dc.contributor.author | Wang, Q | |
| dc.contributor.author | Lavis, JN | |
| dc.date.accessioned | 2025-03-20T18:52:26Z | |
| dc.date.available | 2025-03-20T18:52:26Z | |
| dc.date.issued | 2020-05 | |
| dc.description.abstract | An overview of the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action in response to a decision-maker’s request. | en_US |
| dc.description.sponsorship | The McMaster Health Forum is one of the three co-leads of RISE, which is supported by a grant from the Ontario Ministry of Health to the McMaster Health Forum. | en_US |
| dc.identifier.citation | Waddell K, Wilson MG, Gauvin FP, Mansilla C, Moat KA, Wang Q, Lavis JN. COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action? Hamilton: McMaster Health Forum, 14 May 2020. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/31423 | |
| dc.language.iso | en | en_US |
| dc.relation.ispartofseries | REP 9; | |
| dc.subject | incremental | en_US |
| dc.subject | benefit | en_US |
| dc.subject | history | en_US |
| dc.subject | ageusia | en_US |
| dc.subject | anosmia | en_US |
| dc.subject | screening | en_US |
| dc.subject | COVID-19 | en_US |
| dc.title | COVID-19 rapid evidence profile #9: What is the incremental benefit of using a history of sudden loss of taste (ageusia) and/or smell (anosmia) in symptom screening to identify people who may have COVID-19 and need to take appropriate action? | en_US |